DKY-18269-28347
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 400 / KY
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
- 2020-12-23
- 2020-12-27
- 2020-12-28
- 2020-12-29
-
2021-01-05
Survey response — day 14, dose 1MedDRA: Headache — Feeling: GoodFree text: headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
-
2021-01-28
Survey response — day 14, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: have developed a cold unrelated to vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-09
- 2021-02-18
- 2021-02-25
- 2021-04-13
- 2021-07-14
- 2022-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Free text
Release 1 — day 14, dose 1
Symptoms: headache
Release 2 — day 14, dose 2
Symptoms: have developed a cold unrelated to vaccine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release